Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Modulation of HIV replication in monocyte derived macrophages (MDM) by steroid hormones.

Devadas K, Biswas S, Ragupathy V, Lee S, Dayton A, Hewlett I.

PLoS One. 2018 Jan 26;13(1):e0191916. doi: 10.1371/journal.pone.0191916. eCollection 2018.

2.

Human Immunodeficiency Virus 1 and Type I Interferons-Where Sex Makes a Difference.

Ziegler SM, Altfeld M.

Front Immunol. 2017 Sep 28;8:1224. doi: 10.3389/fimmu.2017.01224. eCollection 2017. Review.

3.

Dendritic cells from the human female reproductive tract rapidly capture and respond to HIV.

Rodriguez-Garcia M, Shen Z, Barr FD, Boesch AW, Ackerman ME, Kappes JC, Ochsenbauer C, Wira CR.

Mucosal Immunol. 2017 Mar;10(2):531-544. doi: 10.1038/mi.2016.72. Epub 2016 Aug 31.

4.

Transgender populations and HIV: unique risks, challenges and opportunities.

Wansom T, Guadamuz TE, Vasan S.

J Virus Erad. 2016 Apr 1;2(2):87-93.

5.
6.

Barriers to a cure for HIV in women.

Gianella S, Tsibris A, Barr L, Godfrey C.

J Int AIDS Soc. 2016 Feb 18;19(1):20706. doi: 10.7448/IAS.19.1.20706. eCollection 2016. Review.

7.

Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy Women.

Thurman AR, Chandra N, Yousefieh N, Zalenskaya I, Kimble T, Asin S, Rollenhagen C, Anderson SM, Herold B, Mesquita PM, Richardson-Harman N, Cunningham T, Schwartz JL, Doncel GF.

AIDS Res Hum Retroviruses. 2016 Jun;32(6):547-60. doi: 10.1089/AID.2015.0264. Epub 2016 Feb 10.

8.

Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.

Weinberg A, Park JG, Bosch R, Cho A, Livingston E, Aweeka F, Cramer Y, Watts DH, Luque AE, Cohn SE.

J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):137-45. doi: 10.1097/QAI.0000000000000850.

9.

Medroxyprogesterone acetate increases HIV-1 infection of unstimulated peripheral blood mononuclear cells in vitro.

Sampah ME, Laird GM, Blankson JN, Siliciano RF, Coleman JS.

AIDS. 2015 Jun 19;29(10):1137-46. doi: 10.1097/QAD.0000000000000681.

10.

Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review.

Johnston RE, Heitzeg MM.

AIDS Res Hum Retroviruses. 2015 Jan;31(1):85-97. doi: 10.1089/AID.2014.0205. Review.

11.

Herpes simplex virus type-2 stimulates HIV-1 replication in cervical tissues: implications for HIV-1 transmission and efficacy of anti-HIV-1 microbicides.

Rollenhagen C, Lathrop MJ, Macura SL, Doncel GF, Asin SN.

Mucosal Immunol. 2014 Sep;7(5):1165-74. doi: 10.1038/mi.2014.3. Epub 2014 Feb 5.

12.

HIV and Menopause: A Systematic Review of the Effects of HIV Infection on Age at Menopause and the Effects of Menopause on Response to Antiretroviral Therapy.

Imai K, Sutton MY, Mdodo R, Del Rio C.

Obstet Gynecol Int. 2013;2013:340309. doi: 10.1155/2013/340309. Epub 2013 Dec 19. Review.

13.

Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior.

Hahn YK, Podhaizer EM, Farris SP, Miles MF, Hauser KF, Knapp PE.

Brain Struct Funct. 2015 Mar;220(2):605-23. doi: 10.1007/s00429-013-0676-6. Epub 2013 Dec 19.

14.

CCR5 expression is reduced in lymph nodes of HIV type 1-infected women, compared with men, but does not mediate sex-based differences in viral loads.

Meditz AL, Folkvord JM, Lyle NH, Searls K, Lie YS, Coakley EP, McCarter M, Mawhinney S, Connick E.

J Infect Dis. 2014 Mar;209(6):922-30. doi: 10.1093/infdis/jit575. Epub 2013 Oct 31.

15.

17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription.

Szotek EL, Narasipura SD, Al-Harthi L.

Virology. 2013 Sep 1;443(2):375-83. doi: 10.1016/j.virol.2013.05.027. Epub 2013 Jun 12.

16.

Estradiol reduces susceptibility of CD4+ T cells and macrophages to HIV-infection.

Rodriguez-Garcia M, Biswas N, Patel MV, Barr FD, Crist SG, Ochsenbauer C, Fahey JV, Wira CR.

PLoS One. 2013 Apr 17;8(4):e62069. doi: 10.1371/journal.pone.0062069. Print 2013.

17.

Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms.

Huijbregts RP, Helton ES, Michel KG, Sabbaj S, Richter HE, Goepfert PA, Hel Z.

Endocrinology. 2013 Mar;154(3):1282-95. doi: 10.1210/en.2012-1850. Epub 2013 Jan 25.

18.

Gardiquimod: a Toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells.

Buitendijk M, Eszterhas SK, Howell AL.

AIDS Res Hum Retroviruses. 2013 Jun;29(6):907-18. doi: 10.1089/AID.2012.0313. Epub 2013 Feb 5.

19.

Hormone replacement therapy and risk for neurodegenerative diseases.

Dye RV, Miller KJ, Singer EJ, Levine AJ.

Int J Alzheimers Dis. 2012;2012:258454. doi: 10.1155/2012/258454. Epub 2012 Apr 4.

20.

CCR5 expression is elevated on endocervical CD4+ T cells in healthy postmenopausal women.

Meditz AL, Moreau KL, MaWhinney S, Gozansky WS, Melander K, Kohrt WM, Wierman ME, Connick E.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):221-8. doi: 10.1097/QAI.0b013e31823fd215.

Supplemental Content

Support Center